Uncovering Disease Heterogeneity with AI and Real-World Data

Oct 29, 2026
Discovery Biology

Assess how AI can integrate multi-modal data to reveal actionable insights across heterogeneous patient populations.

Understand how factors such as disease subtypes and treatment-response variability can inform drug discovery.

Speakers
Sabah Kadri
Sabah Kadri, Senior Director, Head of Quantitative Insights Lab - Abbvie